Crohn Disease
📧 Sign up to get email alerts when something new happens for Crohn Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-06-09Clinical Trial Update: An Australian Study of Mesenchymal Stromal Cells for Crohn's Disease [Phase 2]
Australian Phase 2 trial evaluates mesenchymal stromal cells for Crohn's disease; the study has completed.
-
CLINICAL_TRIALS withdrawal · 2015-06-08Clinical Trial Update: Adjuvant Vitamin D With Corticosteroids in Active Crohn's Disease [Phase 4]
A Phase 4 trial evaluating adjuvant vitamin D with corticosteroids for active Crohn's disease has been withdrawn.
-
FDA approval · 2015-06-03FDA Approved: BUDESONIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for budesonide submitted by Teva Pharmaceuticals USA, Inc.
-
CLINICAL_TRIALS withdrawal · 2015-06-02Clinical Trial Update: Study of Participants With Crohn's Disease and Ulcerative Colitis in Eastern Europe, Middle East, and North Africa (P08166)
A clinical trial (P08166) sponsored by Merck Sharp & Dohme LLC for Crohn's disease and ulcerative colitis has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-05-29Clinical Trial Update: Azathioprine in the Prevention of Ileal Crohn's Disease Postoperative Recurrence. [Phase 2]
A Phase 2 trial evaluating azathioprine to prevent postoperative recurrence of ileal Crohn's disease has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-05-28Clinical Trial Update: A Study to Assess Efficacy, Safety and Tolerability of the Anti-IL-13 Monoclonal Antibody QAX576 in the Treatment of Perinanal Fistulas in Patients Suffering From Crohn's Disease [Phase 2]
Phase 2 study evaluating the anti-IL-13 monoclonal antibody QAX576 for perianal fistulas in Crohn's disease has completed.
-
CLINICAL_TRIALS trial_result · 2015-05-22Clinical Trial Update: "Efficacy and Safety of Infliximab-biosimilar (Inflectra) Compared to Infliximab-innovator (Remicade) in Patients With Inflammatory Bowel Disease in Remission: the SIMILAR Trial" [Phase 4]
Phase 4 trial comparing the infliximab biosimilar Inflectra to Remicade in inflammatory bowel disease patients in remission; current status/…
-
CLINICAL_TRIALS trial_result · 2015-05-15Clinical Trial Update: Impaired Insulin-like Growth Factor-1 (IGF-1) Generation Causes Protein Catabolism and Poor Growth in Children With Crohn Disease
A terminated clinical trial sponsored by Nationwide Children's Hospital studied IGF-1 generation in children with Crohn's disease and found …
-
CLINICAL_TRIALS trial_result · 2015-04-28Clinical Trial Update: Evaluation of the Applicability of the CDEIS to Data Obtained by the Colonic Capsule Endoscopy in Crohn Disease [Phase 4]
Phase 4 study evaluating whether the Crohn's Disease Endoscopic Index of Severity (CDEIS) can be applied to data collected from colonic caps…
-
CLINICAL_TRIALS trial_result · 2015-04-28Clinical Trial Update: Early Immunosuppressants in Crohn's Disease [Phase 4]
Phase 4 trial update on early immunosuppressants for Crohn's disease; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2015-04-20Clinical Trial Update: Dietetic Efficacy of Mare's Milk for Patients With Chronic Inflammatory Bowel Diseases [NA]
A clinical trial evaluated Mare's milk as a dietary treatment for chronic inflammatory bowel diseases (Ulcerative colitis and Crohn's diseas…
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Managing Inflammatory Bowel Disease [NA]
This entry notes the completion of a University of Washington-sponsored clinical trial focused on managing inflammatory bowel disease, inclu…
-
CLINICAL_TRIALS trial_result · 2015-04-13Clinical Trial Update: Nine-Weeks Treatment With 683699 In Subjects With Moderately-To-Severely Active Crohn's Disease [Phase 2]
Phase 2 trial update evaluating nine weeks of treatment with 683699 in patients with moderately to severely active Crohn's disease; the stud…
-
CLINICAL_TRIALS withdrawal · 2015-04-13Clinical Trial Update: Growth Hormone and Exclusion Diet Therapy in Juvenile Crohn's Disease [Phase 2]
A Phase 2 trial evaluating growth hormone plus an exclusion diet for juvenile Crohn's disease has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-04-10Clinical Trial Update: Use of PET-CT in the Management of Crohn's Disease
The trial evaluating PET-CT in the management of Crohn's disease was terminated. No results are provided in this update.
-
CLINICAL_TRIALS trial_result · 2015-04-08Clinical Trial Update: Impact of Infliximab in Fistulizing Crohn's Disease on Health Care Resources (Study P04204)(TERMINATED)
This terminated clinical trial (P04204) evaluated the impact of infliximab for fistulizing Crohn's disease on health care resource use.
-
CLINICAL_TRIALS safety_alert · 2015-04-07Clinical Trial Update: Safety of Anti-tumor Necrosis Factor (TNF) Monoclonal Antibodies in Inflammatory Bowel Disease
This clinical trial update reviews the safety of anti-TNF monoclonal antibodies in inflammatory bowel disease, including ulcerative colitis …
-
CLINICAL_TRIALS research · 2015-04-03Clinical Trial Update: Levels of the Stat4 Alpha and Stat4 Beta Isoforms in PBMCs From Patients With Crohn's Disease and Ulcerative Colitis [NA]
The study measured levels of Stat4 alpha and Stat4 beta isoforms in peripheral blood mononuclear cells from patients with Crohn's disease an…
-
CLINICAL_TRIALS research · 2015-04-01Clinical Trial Update: Autologous Adipose-derived Stem Cells (ASCs) for the Treatment of Perianal Fistula in Crohn Disease: A Pilot Study [Phase 2]
Describes a Phase 2 pilot clinical trial evaluating autologous adipose-derived stem cells for treating perianal fistula in Crohn's disease; …
-
CLINICAL_TRIALS trial_result · 2015-03-31Clinical Trial Update: Efficacy, Safety and Tolerability of AIN457 in Moderate to Severe Active Crohn's Disease [Phase 2]
A Phase 2 trial of AIN457 for moderate-to-severe Crohn's disease was terminated; results assessing efficacy, safety and tolerability were po…
-
CLINICAL_TRIALS trial_result · 2015-03-27Clinical Trial Update: PillCam® Platform With the PillCam Crohn's Disease Capsule [Phase 1, Phase 2]
Clinical trial update for the PillCam platform with the PillCam Crohn's disease capsule completed Phase 1 and Phase 2 with results posted.
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Phase III Randomized Study of Anti-Tumor Necrosis Factor Chimeric Monoclonal Antibody (cA2) for Patients With Enterocutaneous Fistulae as a Complication of Crohn's Disease [Phase 3]
A Phase III randomized trial of the anti-TNF chimeric monoclonal antibody cA2 for enterocutaneous fistulae in Crohn's disease has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Controlled Trial of 4-Aminosalicylic Acid in Patients With Small Bowel Crohn's Disease [NA]
This clinical trial update notes the completion of a controlled trial evaluating 4-aminosalicylic acid in patients with Crohn's disease (sma…
-
CLINICAL_TRIALS trial_result · 2015-03-20Clinical Trial Update: Laquinimod Phase IIa Study in Active Crohn's Disease [Phase 2]
Laquinimod's Phase IIa study in active Crohn's disease has completed.
-
CLINICAL_TRIALS research · 2015-03-19Clinical Trial Update: Observational Study of Disease Severity in Participants Diagnosed With Crohn's Disease and Long Term Impact of Treatment Strategies in Participants With Moderate to Severe Crohn's Disease (Protocol P06484)
This entry outlines the protocol for an observational study of disease severity in Crohn's disease and the long-term impact of treatment str…